| |
|
|
Recommendations - Influenza |
|
|
|
Prevention and Control
of Influenza with Vaccines: Recommendations of the Advisory
Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 26, 2011; 60(33):1128-1132 |
|
|
HTML | PDF |
| |
Antiviral Agents for the
Treatment and Chemoprophylaxis of Influenza
Source: MMWR, January 21, 2011; 60(RR01):1-24 |
|
|
HTML | PDF |
| |
Update: Recommendations of
the Advisory Committee on Immunization Practices (ACIP) Regarding Use
of CSL Seasonal Influenza Vaccine (Afluria) in the United States
During 2010-11
Source: MMWR, August 13, 2010;
59(31):989-92 |
|
| HTML | PDF |
| |
Licensure of a High-Dose
Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone
High-Dose) and Guidance for Use--United States, 2010
Source: MMWR, April 30, 2010; 59(16):485-486 |
|
| HTML | PDF |
| |
Expansion of Use of Live Attenuated
Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other
FluMist Changes for the 2007--08 Influenza Season
Source: MMWR, November
23, 2007; 56(46):1217-1219 |
|
| HTML | PDF |
| |
Influenza Vaccination
of Health-Care Personnel
Source: MMWR, February 24, 2006, Vol. 55(RR02):1-16 |
|
| HTML | PDF |
| |
Using Live, Attenuated Influenza Vaccine
for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB) |
|
| HTML | PDF |
|
| This
page was reviewed on
August 29, 2011 |
A-Z
IAC Home